Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: Longterm results of a phase II study of UFT/CDDP with radiotherapy

International Journal of Clinical Oncology

Volumn 8, Issue 5, 2003, Pages 305-311

  Iwase, Hiroaki ^a   Shimada, Masaaki ^a   Nakamura, Motonori ^a   Nakarai, Keiko ^a   Iyo, Takasi ^a   Kaida, Syogo ^a   Indo, Toshihiko ^a   Kato, Eriko ^a   Horiuchi, You ^b   Kusugami, Kazuo ^c  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b Aichi Saiseikai Hospital   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Cisplatin; Esophageal cancer; Survival; Toxicity; UFT

Indexed keywords

CISPLATIN; UFT;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DIARRHEA; ESOPHAGUS CANCER; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; THROMBOCYTOPENIA; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 10744227027     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0344-6     Document Type: Article

References (35)

1. Rice TW, Adelstein DJ, Zuccaro G, et al. (1997) Advances in the treatment of esophageal carcinoma. Gastroenterogist 5:278-294
2. Roth JA, Putnam JB Jr (1994) Surgery of cancer of the esophagus. Semin Oncol 21:453-461
3. Hancock SL, Glatstein E (1984) Radiation therapy of esophageal cancer. Semin Oncol 11:144-158
4. Rotman MZ (1992) Chemoradiation: a new initiative in cancer treatment. Radiology 184:319-327
5. Lawrence TS, Tepper JE, Blacktock AW (1997) Fluoropyrimidine-radiation interactions in cell and tumors. Semin Oncol 7:260-266
6. Coughlin CT, Richmond RC (1989) Biologic and clinical developments of cisplatinum combined with radiation: concepts utilizing projection for new trial and the emergence of carboplatin. Semin Oncol 16:31-43
7. Coia LR, Engstrom PF, Paul AR, et al. (1991) Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 20:29-36
8. Sakai K, Inakoshi H, Sueyama H, et al. (1994) Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 31:921-927
9. Kelsen DP (2000) Multimodality therapy of esophageal cancer: an update. Cancer J 6:177-181
10. Shimoyama S, Aoki F, Murakami T, et al. (2000) Feasibility of daily concurrent chemoradiation therapy as nonsurgical management for esophageal cancer: our experience and theoretical background. J Surg Oncol 74:134-137
11. Laterza E, Manzoni G, Tedesco P, et al. (1999) Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase II study. Ann Surg Oncol 6:777-784
12. Wilson KS, Lim JT (2000) Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation. Radiother Oncol 54:129-134
13. Stuschke M, Stahl M, Wilke H, et al. (2000) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and mid-thoracic esophagus. Am J Clin Oncol 23:233-238
14. Benulic T, Jncar B (1995) Treatment of advanced esophageal cancer by means of irradiation, cisplatin and 5-fluorouracil. Neoplasma 42:141-145
15. Herskovic A, Marts K, Al-Sarraf M, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of esophagus. N Engl J Med 326:1593-1598
16. Al-Sarraf M, Marts K, Herskovic L, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an Intergroup study. J Clin Oncol 15:277-284
17. Macdonald JS (1999) Oral fluoropyrimidines. A closer look at their toxicities. Am J Clin Oncol 22:475-480
18. Iwase H, Morise K (1992) Chemotherapy combined with radiation for advanced esophageal carcinoma. Intern Med 31:1433-1434
19. Yamakawa M, Niibe H, Honjo J, et al. (1989) Experimental studies on the combined effect of radiation and UFT:1. Radiosensitizing effect of UFT under single X-ray exposure. Jpn J Cancer Chemother 16:3443-3447
20. Yamakawa M, Niibe H, Honjo J, et al. (1990) Experimental studies on the combined effect of radiation and UFT: two fractionated treatments combining UFT and X-ray radiation. Jpn J Cancer Chemother 17:1173-1179
21. Shirasaka T, Shimamoto Y, Ohshima H, et al. (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin I in rodent tumor models in vivo. Cancer Chemother Pharmacol 32:167-172.
22. Hermanek P, Sobin LH (1987) Union Internationale Contre le Cancer. TNM classification of malignant tumors, 4th edn. Springer-Verlag, Geneva Berlin Heidelberg New York Tokyo
23. World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO Offset Publication No. 48. World Health Organization, Geneva
24. Forastiere M, Oriinger MB, Perez-Tamayo C, et al. (1993) Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11:1118-1123
25. Ohtsu A, Boku N, Muro K, et al. (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915-2921
26. Hsu CH, Yen KH, Lui L, et al. (1999) Concurrent chemoradiotherapy for locally advanced esophageal cancer - a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil. Anticancer Res 19:4463-4468
27. Fujii S, Kitano S, Ikenaka K, et al. (1979) Effects of coadministration of uracil or cytosine on the anticancer activity of clinical doses of 1-(2-tetrahydrofury)-5-fluorouracil (FT) and level of 5-fluorouracil in rodents. Gann 70:209-214
28. Kimura K, Suga S, Shimaji T, et al. (1980) Clinical bases of chemotherapy for gastric cancer with uracil and 1-(2-tetrahydrofury)-5-fluorouracil. Gastroenterol Jpn 15:324-329
29. th Inter Cong Chemother (Vienna) 282:45-50
30. Kusunoki M, Yanagi H, Kotera H, et al. (1988) Effects of pharmacokinetic modulating chemotherapy using oral UFT and continuous venous 5FU infusion on the prognosis of irradiated rectal carcinomas with p53 overexpression. Int J Oncol 13:653-657
31. Maeda O, Iwase H, Mamiya N, et al. (2000) Scirrhous cancer of the stomach which survived for more than 5 years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin. Intern Med 39:239-244
32. Suga S, Iawse H, Shimada M, et al. (1996) Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med 35:930-936
33. Jacobs C, Bertino JR, Goffinet DR, et al. (1978) 24-Hour infusion of cis-platinum in head and neck cancers. Cancer 42:2135-2140
34. Kavanagh B, Anschell M, Leopold K, et al. (1992) Patterns of failure following combined modality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 24:633-642
35. Debevec M (1994) Results of nonoperative treatment for esophageal cancer. Radiol Oncol 28:129-133